Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients

Danielle Daitch, Jonathan Daitch, Daniel Novinson, Michael Frey, Carol Mitnick, Joseph Pergolizzi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients'. Together they form a unique fingerprint.

Medicine & Life Sciences